Showing results (111-120 of 124) with videos related to
Sort By:
Pageof 13
Substance Use & Misuse|July 23, 2025
Associations Between Cannabis Messaging and Derived Psychoactive Cannabis Product Perceptions, Use, and Use Intentions Among a Sample of US Young AdultsCassidy R LoParco, Matthew E Rossheim, Yuxian Cui, et al.Substance Abuse Treatment, Prevention, and Policy|January 11, 2025
Cannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adultsCarla J Berg, Cassidy R LoParco, Katelyn F Romm, et al.Journal of Racial and Ethnic Health Disparities|July 15, 2024
Young Adults' Experiences with Cannabis Retailer Marketing and Related Practices: Differences Among Sociodemographic Groups and Associations with Cannabis Use-related OutcomesCarla J Berg, Katelyn F Romm, Cassidy R LoParco, et al.Addictive Behaviors|May 27, 2026
Cannabis retailers' marketing practices and compliance with state regulations: a 2025 point-of-sale audit in 5 U.S. citiesCarla J Berg, Cassidy R LoParco, Matthew E Rossheim, et al.International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.The Lancet. Oncology|December 3, 2020
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse ReactionsCharles L Bennett, Martin W Schoen, Shamia Hoque, et al.Journal of Public Health Management and Practice : JPHMP|June 4, 2024
State Requirements for Non-Medical US Cannabis Retail PersonnelCassidy R LoParco, Yuxian Cui Msph, Darcey McCready Ms, et al.Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.Plos One|August 1, 2019
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactionsCharles L Bennett, Benjamin Schooley, Matthew A Taylor, et al.Pageof 13